drugset / Trial / NCT01528826

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial

NCT01528826 ↗

Phase 2 Unknown 35 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of vinorelbine plus oxaliplatin in pretreated metastatic triple-negative breast cancer.

Timeline

Start
2011-12
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule 90 mg/m2 Intravenous
Subject Vinorelbine Small molecule 30 mg/m2 Intravenous

Indications